Developmental changes of aldehyde oxidase activity in young Japanese children

Clinical Pharmacology and Therapeutics

Volumn 81, Issue 4, 2007, Pages 567-572

  Tayama, Y ^a,b   Miyake, K ^b   Sugihara, K ^a   Kitamura, S ^a,c   Kobayashi, M ^a   Morita, S ^b   Ohta, S ^a   Kihira, K ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLNICOTINAMIDE; ALDEHYDE OXIDASE; DIPYRONE;

AGE; ARTICLE; BIOCHEMICAL COMPOSITION; BIRTH; BODY SURFACE; BODY WEIGHT; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMATURITY; INFANT; JAPAN; LIVER WEIGHT; MALE; NEWBORN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; URINALYSIS;

AGING; ALDEHYDE OXIDASE; BODY SURFACE AREA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LIVER; MALE; NIACINAMIDE; PYRIDONES; SEX CHARACTERISTICS; TWINS, MONOZYGOTIC;

EID: 33947393229     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100078     Document Type: Article

References (32)

1. Beedham, C. Molybdenum hydroxylases: biological distribution and substrate-inhibitor specificity. Prog. Med. Chem. 24, 85-121 (1987).
2. Wright, R.M., Clayton, D.A., Riley, M.G., McManaman, J.L. & Repine, J.E. cDNA cloning, sequencing, and characterization of male and female rat liver aldehyde oxidase (rAOX1). J. Biol. Chem. 274, 3878-3886 (1999).
3. Calzi, M.L. et al. Purification, cDNA cloning, and tissue distribution of bovine liver aldehyde oxidase. J. Biol. Chem. 270, 31037-31045 (1995).
4. Terao, M. et al. Cloning of the cDNAs coding for two novel molybdoflavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase. J. Biol. Chem. 275, 30690-30700 (2000).
5. Berger, R. et al. Analysis of aldehyde oxidase and xanthine dehydrogenase/oxidase as possible candidate genes for autosomal recessive familial amyotrophic lateral sclerosis. Somat. Cell. Mol. Genet. 21, 121-131 (1995).
6. Guo, X. et al. 5-Fluoro-2-pyrimidinone, a liver aldehyde oxidase-activated prodrug of 5-fluorouracil. Biochem. Pharmacol. 49, 1111-1116 (1995).
7. Beedham, C., al-Tayib, Y. & Smith, J.A. Role of guinea pig and rabbit hepatic aldehyde oxidase in oxidative in vitro metabolism of cinchona antimalarials. Drug. Metab. Dispos. 20, 889-895 (1992).
8. Jordan, C.G., Rashidi, M.R., Laljee, H., Clarke, S.E., Brown, J.E. & Beedham, C. Aledehyde oxidase-catalyzed oxidation of methotrexate in the liver of guinea-pig, rabbit and man. J. Pharm. Pharmacol. 51, 411-418 (1999).
9. Clarke, S.E., Harrell, A.W. & Chenery, R.J. Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver. Drug. Metab. Dispos. 23, 251-254 (1995).
10. Rashidi, M.R., Smith, J.A., Clarke, S.E. & Beedham, C. In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver. Drug. Metab. Dispos. 25, 805-813 (1997).
11. Inaba, T., Fayz, S. & Stewart, D.J. Aldehyde oxidase inhibitors for treatment of AIDS. United States Patent 6, 400-434 (2000).
12. Sugihara, K., Kitamura, S. & Tatsumi, K. Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide. Drug. Metab. Dispos. 24, 199-202 (1996).
13. Johnson, T.N. The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 192, 37-48 (2003).
14. Koukouritaki, S.B., Simpson, P., Yeung, C.K., Rettie, A.E. & Hines, R.N. Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr. Res. 51, 236-243 (2002).
15. Kawade, N. & Onishi, S. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in human liver. Biochem. J. 196, 257-260 (1981).
16. Sugihara, K., Tayama, Y., Shimoniya, K., Yoshimoto, D., Ohta, S. & Kitamura, S. Estimation of aldehyde oxidase activity in vivo from conversion ratio of N1-methylnicotinamide to pyridones, and intraspecies variation of the enzyme activity in rats. Drug. Metab. Dispos. 34, 208-212 (2006).
17. Yan, L., Otterness, D.M., Craddock, T.L. & Weinshilboum, R.M. Mouse liver nicotinamide N-methyltransferase: cDNA cloning, expression, and nucleotide sequence polymorphisms. Biochem. Pharmacol. 54, 1139-1149 (1997).
18. Takahashi, H. et al. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children. Clin. Pharmacol. Ther. 68, 541-555 (2000).
19. Yoshihara, S. & Tatumi, K. Involvement of growth hormone as a regulating factor in sex differences of mouse hepatic aldehyde oxidase. Biochem. Pharmacol. 53, 1099-1105 (1997).
20. Beedham, C. Molybdenum hydroxylases as drug metabolizing enzyme. Drug. Metab. Rev. 16, 119-156 (1985).
21. Al-Salmy, H.S. Individual variation in hepatic aldehyde oxidase activity. IUBMB Life 51, 249-253 (2001).
22. Garattini, E., Mendel, R., Romao, M.J., Wright, R. & Terao, M. Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology. Biochem. J. 372, 15-32 (2003).
23. Kurosaki, M. et al. The aldehyde oxidase gene cluster in mice and rats. Aldehyde oxidase homologue 3, a novel member of the molybdoflavoenzyme family with selective expression in the olfactory mucosa. J. Biol. Chem. 279, 50482-50498 (2004).
24. Rodrigues, A.D. Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro. Biochem. Pharmacol. 48, 197-200 (1994).
25. Sugihara, K., Kitamura, S., Tatsumi, K., Asahara, T. & Dohi, K. Differences in aldehyde oxidase activity in cytosolic preparations of human and monkey liver. Biochem. Mol. Biol. Int. 41, 1153-1160 (1997).
26. Kitamura, S., Sugihara, K. & Ohta, S. Drug-metabolizing ability of molybdenum hydroxylases. Drug. Metab. Pharmacokinet. 21, 82-98 (2006).
27. Kitamura, S. et al. Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans. IUBMB Life 48, 607-611 (1999).
28. Shibata, K., Kawada, T. & Iwai, K. Simultaneous micro-determination of nicotinamide and its major metabolites, N1-methyl-2-pyridone-5- carboxamide and N1-methyl-4-pyridone-3-carboxamide, by high-performance liquid chromatography. J. Chromatogr. 424, 23-28 (1988).
29. Haycock, G.B., Schwartz, G.J. & Wisotsky, D.H. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J. Pediatr. 93, 62-66 (1978).
30. Urata, K. et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 21, 1317-1321 (1995).
31. Alcorn, J. & McNamara, P.J. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II. Clin. Pharmacokinet. 41, 1077-1094 (2002).
32. Eggermont, J.J. Mathematical models for developmental changes. Acta Oto-laryngologica. Suppl. 421, 102-107 (1985).